Factor VIII half-life and clinical phenotype of severe hemophilia A.

200596 citationsJournal Article

Authors

Karin van Dijk · De Forensische Zorgspecialisten

Johanna G. van der Bom

Peter J. Lenting

Philip G. de Groot

Eveline P. Mauser‐Bunschoten

G. Roosendaal

Diederick E. Grobbee

H. Marijke van den Berg

Abstract

Among patients with severe hemophilia, treated prophylactically with clotting factor, those with a shorter factor VIII half-life required slightly more clotting factor to prevent joint bleeds and subsequent arthropathy than similar patients with a longer factor VIII half-life.

Topics & Keywords

Hemophilia Treatment and Research Platelet Disorders and Treatments Blood Coagulation and Thrombosis Mechanisms

Publication Details

Published in: PubMed

Volume 90, Issue 4, pp. 494-8

Field-Weighted Citation Impact: 2.17

Command Palette

Factor VIII half-life and clinical phenotype of severe hemophilia A.

Authors

Abstract

Topics & Keywords

Publication Details